ACAMPA, MAURIZIO
 Distribuzione geografica
Continente #
EU - Europa 5.191
NA - Nord America 5.041
AS - Asia 753
SA - Sud America 16
OC - Oceania 15
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 8
AN - Antartide 1
Totale 11.033
Nazione #
US - Stati Uniti d'America 5.019
GB - Regno Unito 1.281
IE - Irlanda 1.028
IT - Italia 694
DE - Germania 673
SE - Svezia 580
CN - Cina 555
UA - Ucraina 364
FR - Francia 245
FI - Finlandia 144
VN - Vietnam 91
RU - Federazione Russa 47
ES - Italia 38
BE - Belgio 25
IN - India 24
GR - Grecia 21
TR - Turchia 17
IR - Iran 16
CA - Canada 14
NL - Olanda 14
AU - Australia 13
SG - Singapore 10
EU - Europa 7
BR - Brasile 6
CL - Cile 6
CZ - Repubblica Ceca 6
IL - Israele 6
AE - Emirati Arabi Uniti 5
CH - Svizzera 5
AT - Austria 4
BD - Bangladesh 4
PH - Filippine 4
EE - Estonia 3
EG - Egitto 3
KG - Kirghizistan 3
KR - Corea 3
RO - Romania 3
AR - Argentina 2
BB - Barbados 2
BY - Bielorussia 2
HK - Hong Kong 2
HR - Croazia 2
ID - Indonesia 2
JP - Giappone 2
MA - Marocco 2
MY - Malesia 2
NG - Nigeria 2
NZ - Nuova Zelanda 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BG - Bulgaria 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GS - Georgia del Sud e Isole Sandwich Australi 1
IQ - Iraq 1
IS - Islanda 1
JM - Giamaica 1
KE - Kenya 1
KW - Kuwait 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
NO - Norvegia 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
PL - Polonia 1
RS - Serbia 1
TH - Thailandia 1
VE - Venezuela 1
Totale 11.033
Città #
Southend 1.165
Dublin 995
Fairfield 800
Chandler 478
Ashburn 417
Woodbridge 335
Wilmington 294
Jacksonville 287
Seattle 281
Cambridge 274
Houston 267
Siena 239
Ann Arbor 234
Princeton 178
Menlo Park 173
Beijing 154
Nanjing 108
Dong Ket 90
Boardman 84
Dearborn 82
Helsinki 82
Vimercate 78
New York 69
San Diego 62
Florence 46
Nanchang 46
Shanghai 45
San Mateo 42
Málaga 33
Mestre 30
Milan 25
Shenyang 25
London 24
Brussels 23
Jiaxing 20
Lancaster 18
Tianjin 18
Changsha 17
Washington 16
San Francisco 15
Jinan 14
Kunming 14
Lappeenranta 14
Hebei 13
Livorno 13
Norwalk 13
Toronto 13
Guangzhou 11
Hangzhou 11
Izmir 11
Pune 11
Rome 11
Arezzo 10
Fremont 10
Los Angeles 9
Ningbo 9
Frankfurt am Main 8
Taizhou 8
Zanjan 8
Melbourne 7
Nicola 7
Paris 7
Perugia 7
Zhengzhou 7
Düsseldorf 6
Hefei 6
Hounslow 6
Prato 6
Queens 6
Sinalunga 6
São Paulo 6
Bonndorf 5
Campi Bisenzio 5
Casalzuigno 5
Kilburn 5
Petah Tikva 5
Sacramento 5
Santiago 5
Caserta 4
Edinburgh 4
Falls Church 4
Leawood 4
Olomouc 4
Phoenix 4
Pisa 4
Poggibonsi 4
Redwood City 4
Rossendale 4
Stockholm 4
Vienna 4
Amsterdam 3
Bagni Di Lucca 3
Bishkek 3
Bologna 3
Canzo 3
Chicago 3
Chittagong 3
Clearwater 3
Cuneo 3
Kolkata 3
Totale 8.070
Nome #
Marked QTc Prolongation and Torsades de pointes in Patients with Chronic Inflammatory Arthritis 238
Arrhythmogenicity of Anti-Ro/SSA antibodies in patients with torsades de pointes 226
Proton pump inhibitors and serum magnesium levels in patients with Torsades de Pointes 223
P wave dispersion in cryptogenic stroke: A risk factor for cardioembolism? 222
Association between high sensitivity C-reactive protein, heart rate variability and corrected QT interval in patients with chronic inflammatory arthritis. 209
Antiarrhythmic potential of anti-cytokine therapy in rheumatoid arthritis: Tocilizumab reduces QTc interval by controlling systemic inflammation. 198
Torsades de Pointes in patients with polymyalgia rheumatica 195
Systemic thrombolysis for stroke in pregnancy 193
Spotlight on sirukumab for the treatment of rheumatoid arthritis: The evidence to date 188
Autonomic activity and baroreflex sensitivity in patients submitted to carotid stenting 182
Endovascular treatment of early recurrent ischemic stroke following intravenous thrombolysis 172
Systemic Inflammation Rapidly Induces Reversible Atrial Electrical Remodeling: The Role of Interleukin-6–Mediated Changes in Connexin Expression 170
Predictors of long-term recovery in complex activities of daily living before discharge from the stroke unit 165
Time Course of Corticospinal Excitability and Autonomic Function Interplay during and Following Monopolar tDCS 165
Anti-Ro/SSA-associated corrected QT interval prolongation in adults: the role of antibody level and specificity 163
Delineation of the phenotype associated with 7q36.1q36.2 deletion: long QT syndrome, renal hypoplasia and mental retardation 160
Thrombolytic treatment of cardiac myxoma-induced ischemic stroke: a review 157
Connective tissue diseases and cardiac rhythm disorders: an overview 156
Stroke warning syndrome: 18 new cases. 156
Double ophthalmic arteries arising from the internal carotid artery. A case report of a hidden second ophthalmic artery 154
Safety of intravenous thrombolysis in ischemic stroke caused by left atrial myxoma 151
How to Identify Patients at Risk of Silent Atrial Fibrillation after Cryptogenic Stroke: Potential Role of P Wave Dispersion 150
Microvascular abnormalities in Rett Syndrome 150
Prolongation of the corrected QT interval in adult patients with anti-Ro/SSA positive connective tissue diseases 146
Comparison of frequency of complex ventricular arrhythmias in patients with positive versus negative anti-Ro/SSA and connective tissue disease 145
Increased arterial stiffness is an independent risk factor for hemorrhagic transformation in ischemic stroke undergoing thrombolysis 145
Early and delayed increase in plasma homocysteine levels in heart transplanted patients. 144
Previous use of statins and atrial electrical remodeling in patients with cryptogenic stroke 144
Genetic influence in antithrombotic actions of atorvastatin in hypercholesterolaemia 142
Neuroimaging and definition of transient ischemic attack 142
null 141
Prediction of Early Recurrent Thromboembolic Event and Major Bleeding in Patients With Acute Stroke and Atrial Fibrillation by a Risk Stratification Schema: The ALESSA Score Study. 141
Cardiac dysautonomia and serotonin plasma levels in Rett syndrome 140
Pravastatin treatment-associated reduction in plasma homocysteine in heart-transplanted patients. 140
Cardiac autonomic nervous system and risk of arrhythmias in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL). 135
Inflammatory cytokines, life-threatening arrhythmias and premature mortality in chronic inflammatory arthritis: Time to focus on 134
Cardiac dysautonomia and arterial distensibility in essential hypertensives 133
Autoantibody-mediated cardiac arrhythmias: mechanisms and clinical implications 132
Arrhythmic risk in rheumatoid arthritis: the driving role of systemic inflammation. 131
Sympathetic overactivity and plasma leptin levels in Rett syndrome 131
Relationship between the modified Rankin Scale and the Barthel Index in the process of functional recovery after stroke 129
null 124
Electromagnetic fields produced by incubators influence heart rate variability in newborns 123
Cardiac dysautonomia in patients with superior vena cava syndrome due to compression by lung cancer. 122
null 122
Autonomic dysfunction in mental retardation and spastic paraparesis with MECP2 mutation. 122
Acute effects of glibenclamide on reactive hyperaemia in the lower limbs in humans. 121
Pharmacogenetics of statins therapy 117
Atrial cardiopathy and sympatho-vagal imbalance in cryptogenic stroke: Pathogenic mechanisms and effects on electrocardiographic markers 116
Corrected QT interval in anti-SSA-positive adults with connective tissue disease: Comment on the article by Lazzerini et al. [6] (multiple letters) 114
Cardiac arrest risk during acute infections: systemic inflammation directly prolongs QTc interval via cytokine-mediated effects on potassium channel expression 114
Androgen Deprivation Therapy for Prostatic Cancer in Patients With Torsades de Pointes 113
Sudden death and cardiac arrhythmias in Rett syndrome 113
Oral low-dose dipyridamole protects from intravenous high-dose dipyridamole-induced ischemia. A oral echocardiographic study 108
Aortic stiffness in patients with deep and lobar intracerebral hemorrhage: role of antihypertensive drugs and statins: response to letter 108
Proton pump inhibitors directly block hERG-potassium channel and independently increase the risk of QTc prolongation in a large cohort of US Veterans 106
Arrhythmic risk during acute infusion of infliximab: a prospective, single-blind, placebo-controlled, cross-over study in patients with chronic arthritis 104
Nerve growth factor plasma levels and ventricular repolarization in Rett syndrome 102
Cranial osteolytic metastases as the only recurrence of gastric carcinoma 101
Homocysteine and P wave dispersion in patients with heart transplantation 101
Effects of acetyl-L-carnitine on cardiac dysautonomia in Rett syndrome: prevention of sudden death? 101
Arrhythmogenic effects of anti-Ro/SSA antibodies on theadult heart: more than expected? 97
Anticoagulation after Stroke in Patients with Atrial Fibrillation: To Bridge or Not with Low-Molecular-Weight Heparin? 90
Effects of acute administration of iloprost on the cardiac autonomic nervous system and ventricular repolarisation in patients with systemic sclerosis 89
P wave dispersion and silent atrial fibrillation in cryptogenic stroke: The pathogenic role of inflammation 88
Bosentan treatment on Raynaud Phenomenon and Skin Fibrosis in Patients with Systemic Sclerosis and with Pulmonary Arterial Hypertension: an open-label, observational, retrospective study 85
Anti-Ro/SSA Antibodies Blocking Calcium Channels as a Potentially Reversible Cause of Atrioventricular Block in Adults 82
Electrocardiographic Predictors of Silent Atrial Fibrillation in Cryptogenic Stroke 78
Hemorrhagic transformation in patients with acute ischemic stroke and atrial fibrillation: Time to initiation of oral anticoagulant therapy and outcomes 76
Risk of qtc interval prolongation associated with circulating anti-ro/ssa antibodies among us veterans: an observational cohort study 70
Early recurrence and major bleeding in patients with acute ischemic stroke and atrial fibrillation treated with Non-Vitamin-K oral anticoagulants (RAF-NOACs) Study 67
null 65
Safety of anticoagulation in patients treated with urgent reperfusion for ischemic stroke related to atrial fibrillation 61
null 61
Increased Arterial Stiffness is a Predictor of Delayed Ischaemic Stroke After Subarachnoid Haemorrhage 61
Transient hypogonadism is associated with heart rate-corrected QT prolongation and torsades de pointes risk during active systemic inflammation in men 60
Timing of initiation of oral anticoagulants in patients with acute ischemic stroke and atrial fibrillation comparing posterior and anterior circulation strokes 57
Increased arterial stiffness is associated with poor collaterals in acute ischemic stroke from large vessel occlusion 57
Acute ischemic stroke and concomitant massive pulmonary embolism: a challenge 56
Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke 54
Cardiac disease and Rett syndrome 51
Inflammation and Atrial Electrical Remodelling in Patients With Embolic Strokes of Undetermined Source 51
Letter regarding “Combined aspiration thrombectomy and continuous intrasinus thrombolysis for cerebral venous sinus thrombosis: technical note and case series” 50
Practical "1-2-3-4-Day" Rule for Starting Direct Oral Anticoagulants After Ischemic Stroke With Atrial Fibrillation: Combined Hospital-Based Cohort Study 49
Single-center experience using the 3MAX or 4MAX reperfusion catheter for the treatment of acute ischemic stroke with distal arterial occlusions in patients not eligible for intravenous fibrinolysis 46
Autonomic nervous system alterations in Rett syndrome 46
Non-stenosing carotid atherosclerosis and arterial stiffness in embolic stroke of undetermined source 44
Interleukin-6 elevation Is a key pathogenic factor underlying COVID-19-Associated heart rate-corrected QT interval prolongation 43
Outcome after acute ischemic stroke treatment during Covid-19 outbreak in South-East Tuscany 42
Causes and Risk Factors of Cerebral Ischemic Events in Patients with Atrial Fibrillation Treated with Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention: The RENo Study 39
Perioperative stroke and hyperhomocysteinemia: A possible pathogenic link 38
To the Editor— Anticoagulation in atrial fibrillation after intracranial hemorrhage: Could the hemorrhage location influence the outcome? 38
Oral anticoagulants in the oldest old with recent stroke and atrial fibrillation 37
Letter by Acampa et al Regarding Article, "Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage in Patients With a History of Migraine" 36
Reduced heart rate variability in patients affected with Rett syndrome. A possible explanation for sudden death 36
Risk factors for intracerebral hemorrhage in patients with atrial fibrillation on Non-Vitamin K antagonist oral anticoagulants for stroke prevention 34
Postoperative atrial fibrillation and ischemic stroke: The role of homocysteine 28
Unravelling atrioventricular block risk in inflammatory diseases: systemic inflammation acutely delays atrioventricular conduction via a cytokine-mediated inhibition of connexin43 expression 27
Maternal Anti-Ro/SSA Autoantibodies and Prolonged PR Interval in a Competitive Athlete: Beyond Training-Induced Electrical Remodeling 27
Ischemic stroke after heart transplantation 27
Totale 11.033
Categoria #
all - tutte 38.355
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.355


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019250 0 0 0 0 0 0 0 0 0 0 0 250
2019/20202.064 216 96 119 269 105 252 212 254 164 197 65 115
2020/20211.786 98 156 78 194 78 170 113 202 255 136 154 152
2021/20221.561 114 157 54 130 78 27 56 154 123 128 226 314
2022/20231.837 114 218 247 233 148 339 72 130 150 60 85 41
2023/20241.815 62 27 158 111 87 499 558 47 34 51 118 63
Totale 11.352